GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications originally designed to help regulate blood sugar in people with type 2 diabetes
Gently massage until fully absorbed
More research is needed to determine whether similar effects occur with other weight-loss medications, including newer drugs such as those used in Zepbound
Key timelines to know: As early as May 2026 : Medicaid GLP-1 coverage for obesity could begin in participating states
Water, stabilizer polydextrose, acidity regulator citric acid, carbon dioxide, L-carnitine, taurine, flavouring, preservatives (potassium sorbate, sodium benzoate), sweetener acesulfame K, caffeine, sweetener sucralose, colourings quinoline yellow may adversely affect the activity and attention of children and brilliant blue FCF